Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
9M
-
Shares change
-
+1.05M
-
Total reported value, excl. options
-
$85.8M
-
Value change
-
+$10.1M
-
Put/Call ratio
-
1.71
-
Number of buys
-
47
-
Number of sells
-
-38
-
Price
-
$9.54
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q1 2021
116 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q1 2021.
Co-Diagnostics, Inc. - Common Stock (CODX) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9M shares
of 38.5M outstanding shares and own 23.36% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.96M shares), VANGUARD GROUP INC (1.83M shares), Nuveen Asset Management, LLC (792K shares), STATE STREET CORP (443K shares), GEODE CAPITAL MANAGEMENT, LLC (436K shares), NORTHERN TRUST CORP (287K shares), WELLS FARGO & COMPANY/MN (266K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (212K shares), Russell Investments Group, Ltd. (172K shares), and PRINCIPAL FINANCIAL GROUP INC (162K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.